14 results
Causes of Dyspnea by System #Diagnosis #EM #IM #PCC #Dyspnea #ShortnessOfBreath #Differential #Algorithm #Ddxof
Diagnosis #EM #IM ... #PCC #Dyspnea # ... #Differential #Algorithm
Pleural Effusion - Workup, Diagnostic Algorithm #Diagnosis #EM #IM #PCC #Pleural #Effusion #Transudative #Exudative #Differential #Algorithm
Workup, Diagnostic Algorithm ... Diagnosis #EM #IM ... #PCC #Pleural # ... #Differential #Algorithm
Assessment and Treatment of Severe Asthma, According to Inflammatory Phenotypes, in Patients without a Response to
Treatment of Severe Asthma ... #Management #PCC ... #Asthma #Severe ... #Algorithm #Phenotypes ... #NEJM
Algorithm and Causes of an Elevated Hemidiaphragm #Diagnosis #Radiology #EM #IM #PCC #Elevated #Hemidiaphragm #ElevatedHemidiaphragm #Diaphragm
Algorithm and Causes ... Radiology #EM #IM ... #PCC #Elevated ... #Differential #Algorithm
Consensus diagnostic criteria for asthma-COPD overlap syndrome (ACOS) in patients with airflow limitation. COPD=chronic obstructive pulmonary
diagnostic criteria for asthma-COPD ... normal #Diagnosis #PCC ... #IM #ACOS #AsthmaCOPD ... OverlapSyndrome #Asthma
An Integrated Multidisciplinary Approach to Assessment and Initial Management of Difficult-to-Treat and Severe Asthma in Adults.
Difficult-to-Treat and Severe Asthma ... glucocorticoids #Management #PCC ... #Asthma #Severe ... #Algorithm #Multidisciplinary ... DifficultToTreat #Assessment #NEJM
A good approach when dealing with hypotension at the bedside includes using the following systematic four
Management #EM #IM ... #PCC #Hypotensive ... Hypotension #Approach #Algorithm
Features Associated with Pathobiologic Characteristics of Severe Asthma, According to Phenotype. #Diagnosis #PCC #Asthma #Severe #Phenotypes
Characteristics of Severe Asthma ... #Diagnosis #PCC ... #Asthma #Severe ... Hyperresponsive #Fixed #NEJM
Possible mechanisms for the development of asthma-COPD overlap syndrome (ACOS). Two mechanisms by which ACOS might
development of asthma-COPD ... #Pathophys #PCC ... #IM #ACOS #AsthmaCOPD ... OverlapSyndrome #Asthma
Tezepelumab in Adults with Uncontrolled Asthma - Annualized Rate of Asthma Exacerbations at Week 52, According
with Uncontrolled Asthma ... Annualized Rate of Asthma ... Nitric Oxide #EBM #PCC ... #Asthma #Tezepelumab ... #NEJM